Vol.

No.

February 07, 2025Feb 07, 2025

DOWNLOAD THE PDF

“Page Not Found:” HHS agencies purge web pages that hint at DEI, health equity, and gender Medical group sues over removing “information used every day by health professions”

Cover Story

White House

“Page Not Found:” HHS agencies purge web pages that hint at DEI, health equity, and gender

Medical group sues over removing “information used every day by health professions”

By Jacquelyn Cobb and Katie Goldberg

The web page for the FDA Office of Minority Health and Health Equity is no more.

Capitol Hill

Senate Finance Committee advances RFK Jr. to likely confirmation, with Bill Cassidy (R-LA) casting the deciding vote

By Claire Marie Porter

Guest Editorial

Communication—We need more, not less

By W. Kimryn Rathmell

Guest Editorial

World Cancer Day 2025: A symbol of personal and collective uncertainty

By Ruth Fein Revell

Clinical Trials & Tribulations

LLS former CSO: Immunotherapy, precision medicine redefined blood cancer treatment

By Lee Greenberger

At City of Hope, our path to innovation includes surgical simulations in space, diverse genomics data—and more

By City of Hope

Clinical Trials & Tribulations

Physicians and biopharma should improve accessibility of cancer trials

By Michel van Harten

Black History Month Free In the Archives

Marsha Henderson: “You have to continue to push for what you think is the right thing for public health.”
Preserving an oral history by the former FDA associate commissioner of women’s heath

By Katie Goldberg

In Brief

ASCO to recognize 11 Special Awards recipients at the 2025 annual meeting

Walter Stadler appointed chief clinical officer at City of Hope Cancer Center Chicago

UCLA awarded $1.72M NIH grant to train brain cancer scientists

TGH Cancer Institute awarded QOPI Certification

COA proposes health care reform blueprint

Wistar receives $600,000 grant to expand apprenticeship programs

Clinical Roundup

Pre-surgery immunotherapy boosts breast cancer treatment success, phase III trial finds

Cancer vaccine shows promise for patients with stage 3 and 4 kidney cancer

UCLA-led study establishes link between early side effects from prostate cancer radiation and long-term side effects

Thyroid cancer continues to be overdiagnosed, Cedars-Sinai study finds

Inherited WNT9B mutation linked to increased prostate cancer risk, study finds

Healthy stem cells could turn into oral cancer, study finds

Wistar researchers identify target to overcome treatment-resistant melanoma

Urine test for prostate cancer could be used at home, study finds

Drugs & Targets

FDA grants orphan drug designation to MB-105 for CD5-targeted CAR T-cell therapy

CHMP recommends approval of Opdivo + Yervoy for unresectable or advanced HCC

CHMP recommends approval Breyanzi for r/r follicular lymphoma

NCI Trials

NCI Trials for February 2025

The National Cancer Institute approved the following clinical research studies last month.

PREVIOUS ISSUE

CURRENT ISSUE

Recent Issues

Volume 51 | Issue 05 - February 07, 2025